Indication
Hairy cell leukemia
Hairy cell leukemia is a rare, indolent B-cell lymphoproliferative neoplasm characterized by the accumulation of mature, abnormal clonal B lymphocytes primarily within the bone marrow, spleen, and peripheral blood. Read more about Hairy cell leukemia
20 drugs 16 manufacturers
Drugs that treat it
Common Hairy cell leukemia therapies.
CLADRIBINE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHairy cell leukemia is a rare, indolent B-cell lymphoproliferative neoplasm characterized by the accumulation of mature, abnormal clonal B lymphocytes primarily within the bone marrow, spleen, and peripheral blood.
It predominantly affects adults, with a marked male predominance and a median age at diagnosis in the mid-fifties.
Pathophysiologically, the malignant cells exhibit characteristic fine, hair-like cytoplasmic projections and typically harbor the activating *BRAF* V600E mutation, leading to constitutive MAPK pathway signaling.
Progressive leukemic infiltration of hematopoietic tissue and the splenic red pulp results in bone marrow reticulin fibrosis, pronounced splenomegaly, and cytopenias, particularly profound monocytopenia, anemia, and neutropenia that predispose patients to recurrent infections.
- nih.gov
Hairy cell leukemia is a rare, indolent B-cell lymphoproliferative neoplasm characterized by the accumulation of mature, abnormal clonal B lymphocytes primarily within the bone marrow, spleen, and peripheral blood It predominantly affects adults, with a marked male predominance and a median age at diagnosis in the mid-fifties Progressive leukemic infiltration of hematopoietic tissue and the splenic red pulp results in bone marrow reticulin fibrosis, pronounced splenomegaly, and cytopenias, parti...
- nih.gov
Hairy cell leukemia is a rare, indolent B-cell lymphoproliferative neoplasm characterized by the accumulation of mature, abnormal clonal B lymphocytes primarily within the bone marrow, spleen, and peripheral blood Pathophysiologically, the malignant cells exhibit characteristic fine, hair-like cytoplasmic projections and typically harbor the activating *BRAF* V600E mutation, leading to constitutive MAPK pathway signaling Progressive leukemic infiltration of hematopoietic tissue and the splenic r...
- nih.gov
It predominantly affects adults, with a marked male predominance and a median age at diagnosis in the mid-fifties Pathophysiologically, the malignant cells exhibit characteristic fine, hair-like cytoplasmic projections and typically harbor the activating *BRAF* V600E mutation, leading to constitutive MAPK pathway signaling Progressive leukemic infiltration of hematopoietic tissue and the splenic red pulp results in bone marrow reticulin fibrosis, pronounced splenomegaly, and cytopenias, particul...
- nih.gov
Pathophysiologically, the malignant cells exhibit characteristic fine, hair-like cytoplasmic projections and typically harbor the activating *BRAF* V600E mutation, leading to constitutive MAPK pathway signaling
Personalize your experience
Follow Hairy cell leukemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.